Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Baseline characteristics of a diagnostically defined early psychosis cohort entering supported employment and education: findings from the SEEearly trial.

European archives of psychiatry and clinical neuroscience·2026

Same author

Early Detection of Lower Adherence to Long-Term e-Diary Recording: A Checkpoint to Target Early Educational Intervention in Seasonal Allergic Rhinitis?

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026

Same author

Objective and subjective assessment of back shape and function in persons with and without low back pain.

Scientific reports·2025

Same author

Assessing post-stroke cognition in pre-clinical models: lessons and recommendations from a multi-center study.

bioRxiv : the preprint server for biology·2025

Same author

Heterogeneity of sensitization profiles and clinical phenotypes among patients with seasonal allergic rhinitis in Southern European countries-The @IT.2020 multicenter study.

Allergy·2024

Same author

Quality measurement of out-patient neuropsychological therapy after stroke in Germany: definition of indicators and retrospective pilot study.

BMC neurology·2021

Search research articles

Related Experiment Videos

Predicting post-stroke pneumonia: the PANTHERIS score.

H Harms¹, U Grittner, H Dröge

¹Center for Stroke Research Berlin (CSB), Charité - Universitaetsmedizin Berlin, Berlin, Germany. hendrik.harms@charite.de

Acta Neurologica Scandinavica

|March 7, 2013

Summary

This summary is machine-generated.

A new PANTHERIS score helps identify patients at high risk of stroke-associated pneumonia (SAP). This tool aids in implementing early monitoring and prophylactic measures to improve outcomes after ischemic stroke.

Keywords:

glasgow coma scale predictive score stroke stroke-associated pneumonia systolic hypertension

Related Experiment Videos

Area of Science:

Neurology
Critical Care Medicine
Infectious Disease Epidemiology

Background:

Stroke-associated pneumonia (SAP) is a frequent complication following acute ischemic stroke.
SAP significantly worsens neurological outcomes and increases patient mortality.
Early identification of high-risk patients is crucial for implementing timely interventions.

Purpose of the Study:

To develop and validate a predictive scoring system for stroke-associated pneumonia (SAP).
To identify key clinical factors associated with SAP development in acute ischemic stroke patients.
To facilitate targeted prophylactic strategies for high-risk individuals.

Main Methods:

A cohort study was conducted on 335 patients with acute ischemic MCA infarction admitted to a neurological intensive care unit.
Logistic regression analysis identified significant predictors of SAP.
A 12-point scoring system (PANTHERIS score) was developed using Glasgow Coma Scale, age, systolic blood pressure, and white blood cell count.

Main Results:

The overall frequency of SAP was 31.3% in the study cohort.
The developed PANTHERIS score demonstrated excellent predictive performance with an AUC of 0.85.
The score showed good calibration and was validated internally, confirming its predictive properties.

Conclusions:

The PANTHERIS score is a simple and effective tool for predicting SAP in acute ischemic stroke patients.
It utilizes easily assessable parameters, making it practical for clinical use.
The score can guide intensified monitoring and prophylactic measures, potentially improving patient outcomes, but requires external validation.